These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37852102)

  • 1. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice.
    Wayal V; Hsieh CC
    Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
    Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
    Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosa Mosqueta Oil Prevents Oxidative Stress and Inflammation through the Upregulation of PPAR-α and NRF2 in C57BL/6J Mice Fed a High-Fat Diet.
    González-Mañán D; D'Espessailles A; Dossi CG; San Martín M; Mancilla RA; Tapia GS
    J Nutr; 2017 Apr; 147(4):579-588. PubMed ID: 28298541
    [No Abstract]   [Full Text] [Related]  

  • 5. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress.
    Wei K; Wei Y; Xu W; Lu F; Ma H
    Food Funct; 2022 May; 13(10):5782-5793. PubMed ID: 35537139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
    Chen HL; Tsai TC; Tsai YC; Liao JW; Yen CC; Chen CM
    Nutr Diabetes; 2016 Dec; 6(12):e237. PubMed ID: 27941940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
    Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA
    Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
    Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
    Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
    Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice.
    Shankar K; Metzger NP; Lawrence C; Gupta D; Osborne-Lawrence S; Varshney S; Singh O; Richard CP; Zaykov AN; Rolfts R; DuBois BN; Perez-Tilve D; Mani BK; Hammer STG; Zigman JM
    Mol Metab; 2024 Jun; 84():101950. PubMed ID: 38697291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baked corn (Zea mays L.) and bean (Phaseolus vulgaris L.) snack consumption lowered serum lipids and differentiated liver gene expression in C57BL/6 mice fed a high-fat diet by inhibiting PPARγ and SREBF2.
    Dominguez-Uscanga A; Loarca-Piña G; Gonzalez de Mejia E
    J Nutr Biochem; 2017 Dec; 50():1-15. PubMed ID: 28965030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.
    Tao W; Sun W; Liu L; Wang G; Xiao Z; Pei X; Wang M
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31744059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats.
    Farage AE; Abdo W; Osman A; Abdel-Kareem MA; Hakami ZH; Alsulimani A; Bin-Ammar A; Alanazi AS; Alsuwayt B; Alanazi MM; Antar SA; Kamel EM; Mahmoud AM
    Life Sci; 2023 Jun; 322():121688. PubMed ID: 37030617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridostigmine attenuated high-fat-diet induced liver injury by the reduction of mitochondrial damage and oxidative stress via α7nAChR and M3AChR.
    Xue R; Wu Q; Guo L; Ye D; Cao Q; Zhang M; Xian Y; Chen M; Yan K; Zheng J
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23671. PubMed ID: 38454809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
    Tetri LH; Basaranoglu M; Brunt EM; Yerian LM; Neuschwander-Tetri BA
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G987-95. PubMed ID: 18772365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
    Shen S; Wang K; Zhi Y; Dong Y
    Pharm Biol; 2022 Dec; 60(1):1949-1959. PubMed ID: 36205541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
    Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
    Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria.
    García-Berumen CI; Ortiz-Avila O; Vargas-Vargas MA; Del Rosario-Tamayo BA; Guajardo-López C; Saavedra-Molina A; Rodríguez-Orozco AR; Cortés-Rojo C
    Lipids Health Dis; 2019 Mar; 18(1):78. PubMed ID: 30927921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.